Inspection of a deviation from Hardy-Weinberg equilibrium in familial breast cancer cases from a case-control study in a meta-analysis

Breast Cancer Research and Treatment

Volumn 127, Issue 2, 2011, Pages 577-579

  Yu, Ke Da ^a,b   Shao, Zhi Ming ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Breast cancer; Hardy Weinberg equilibrium; Meta analysis

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CASP8 GENE; COPY NUMBER VARIATION; FAMILIAL CANCER; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HARDY WEINBERGY EQUILIBRIUM; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LETTER; META ANALYSIS (TOPIC); ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; HUMANS; META-ANALYSIS AS TOPIC;

EID: 79958225412     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1361-1     Document Type: Letter

References (7)

1. Ziegler A, Van Steen K, Wellek S (2010) Investigating Hardy-Weinberg equilibrium in case-control or cohort studies or meta-analysis. Breast Cancer Res Treat. doi: 10.1007/s10549-10010-11295-z
2. B Frank SH Rigas JL Bermejo M Wiestler K Wagner K Hemminki MW Reed C Sutter B Wappenschmidt SP Balasubramanian A Meindl M Kiechle P Bugert RK Schmutzler CR Bartram C Justenhoven YD Ko T Bruning H Brauch U Hamann PP Pharoah AM Dunning KA Pooley DF Easton A Cox B Burwinkel 2008 The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter study Breast Cancer Res Treat 111 139 144 17891485 10.1007/s10549-007-9752-z 1:CAS:528: DC%2BD1cXos1WnsL4%3D (Pubitemid 352009221)
3. KD Yu GH Di L Fan ZM Shao 2009 Test of Hardy-Weinberg equilibrium in breast cancer case-control studies: an issue may influence the conclusions Breast Cancer Res Treat 117 675 677 19242790 10.1007/s10549-009-0353-x
4. J Ragoussis GP Elvidge K Kaur S Colella 2006 Matrix-assisted laser desorption/ionisation, time-of-flight mass spectrometry in genomics research PLoS Genet 2 e100 16895448 10.1371/journal.pgen.0020100 (Pubitemid 44147397)
5. B Pesch Y Ko H Brauch U Hamann V Harth S Rabstein C Pierl HP Fischer C Baisch C Justenhoven U Ranft T Bruning 2005 Factors modifying the association between hormone-replacement therapy and breast cancer risk Eur J Epidemiol 20 699 711 16151884 10.1007/s10654-005-0032-0 (Pubitemid 41266867)
6. Catucci I, Verderio P, Pizzamiglio S, Manoukian S, Peissel B, Zaffaroni D, Roversi G, Ripamonti CB, Pasini B, Barile M, Viel A, Giannini G, Papi L, Varesco L, Martayan A, Riboni M, Volorio S, Radice P, Peterlongo P (2010) The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers. Breast Cancer Res Treat. doi: 10.1007/s10549-10010-11068-10548
7. S Geneletti S Richardson N Best 2009 Adjusting for selection bias in retrospective, case-control studies Biostatistics 10 17 31 18482997 10.1093/biostatistics/kxn010 (Pubitemid 352847903)